NCT06878131View on ClinicalTrials.gov

Precision-MRD: Prospective Observational Study of Biomarker-directed Systemic Therapy for Colorectal Cancer Patients With Minimal Residual Disease

Not yet recruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

December 22, 2026

Study Completion Date

December 22, 2028

Conditions
Colorectal Cancer
Interventions
BEHAVIORAL

Colorectal Cancer

Participants that take part in this research, will be responsible for following study directions and allowing blood samples to be collected every 3 months for correlative studies.

Trial Locations (1)

77030

MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER